Neuromodulation : journal of the International Neuromodulation Society
-
Intrathecal morphine (ITM) is commonly used for the treatment of cancer pain. There is reluctance for its use in France to treat chronic noncancer pain. In order to appreciate its popularity, efficacy, dose escalation with time, and long-term tolerance, we carried out a retrospective study in the neurosurgery departments of university teaching hospitals in France involved in intrathecal drug therapy. ⋯ Side effects imputable to morphine included; constipation, somnolence, decreased libido, weight gain, amenorrhoea, vomiting, nightmares, and itching. No development of tolerance or addiction were recorded. We conclude that in well selected cases ITM should be considered as a possible therapeutic option in the treatment of intractable chronic benign pain.
-
The objective of this paper is to assess the outcome of implanted multiple thoracolumbar lead spinal cord stimulation (SCS) in mechanical back pain without prior spinal surgery. These results are compared with intrathecal opioid drug delivery (ITDD). An anonymous third party patient questionnaire study of pain relief, function and psychosocial quality of life measures (recorded on 11-point numerical rating scales) for 12 patients with SCS and 13 with ITDD was used. ⋯ The majority of psychosocial quality of life measures were significantly more improved in the ITDD group compared with the SCS group (p < 0.05). We conclude that multiple-lead SCS improves mechanical back pain in patients unresponsive to more conservative measures. However, ITDD provides significantly more improved quality of life measures, with a trend towards greater pain reduction than SCS.
-
This report outlines a case of refractory insomnia temporally related to migration of cervical spinal cord stimulator leads. To our knowledge this association is previously unreported. ⋯ A brief review of insomnia and its complex relationship to chronic pain is presented. We hope that this case will stimulate further discussion and possibly bring to light new insights into spinal cord stimulation and insomnia and alert others to this possible clinical association of symptoms.
-
The objective of this study was to compare the technical performance of laminectomy and percutaneous spinal cord stimulation leads with similar contact spacing by computer modeling. Monopolar and tripolar (guarded cathode) stimulation with both lead types in a low-thoracic spine model was simulated using UT-SCS software. Dorsal column and dorsal root fiber thresholds were calculated as well as the area of recruited fibers in the dorsal columns, the rostrocaudal span of recruited dorsal root fibers and the energy consumption at discomfort threshold. ⋯ A deterioration of all performance parameters is predicted when a percutaneous lead is placed more dorsally in the epidural tissue. When positioned next to the dura mater, a percutaneous lead has a similar performance (fiber recruitment in the dorsal columns and the dorsal roots) as a laminectomy lead with similar contact spacing, but substantially higher energy consumption. The superior clinical performance of the laminectomy lead is most probably due to the difference in volume and insertion technique of the two lead types.
-
The objective of this study was to evaluate the stimulation responses on each channel of an implantable two-channel stimulator that stimulates the peroneal nerve branches innervating the muscles for dorsiflexion and eversion movements. Currently five Dutch patients and five English patients have been implanted with this system. Isometric ankle torque measurements were carried out in the patient with the longest follow-up period (1 y). ⋯ Eversion moments are determined mainly by channel 2 and to a lesser extent by channel 1. Both channels determined abduction/adduction moments. We conclude that stimulation responses in both dorsiflexion and eversion direction can be set individually and with great accuracy and are reproducible over a prolonged period.